Comparative Evaluation of a Low-Carbohydrate Diet and a Mediterranean Diet in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A 16-Week Intervention Study
Open accessThe DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
Introduction: The worldwide prevalence of type 2 diabetes mellitus (T2DM) and obesity has been steadily increasing over the past four decades, with projections indicating a significant rise in the number of affected individuals by 2045. Therapeutic interventions in T2DM aim to control blood glucose levels and reduce the risk of complications. Dietary and lifestyle modifications play a crucial role in the management of T2DM and obesity. While conventional medical nutritional therapy (MNT) often promotes a high-carbohydrate, low-fat Mediterranean diet as an elective treatment, low-carbohydrate diets (LCDs), specifically those restricting carbohydrate intake to less than 130 g/day, have gained popularity due to their multifaceted benefits. Scientific research supports the efficacy of LCDs in improving glycemic control, weight loss, blood pressure, lipid profiles, and overall quality of life. However, sustaining these benefits over the long term remains challenging. This trial aimed to compare the effects of a Mediterranean diet vs. a low-carbohydrate diet (carbohydrate intake < 130 g/day) on overweight/obese patients with T2DM over a 16-week period. The study will evaluate the differential effects of these diets on glycemic regulation, weight reduction, lipid profile, and cardiovascular risk factors. Methods: The study population comprises 100 overweight/obese patients with poorly controlled T2DM. Anthropometric measurements, bioimpedance analysis, and blood chemistry assessments will be conducted at baseline and after the 16-week intervention period. Both dietary interventions were hypocaloric, with a focus on maintaining a 500 kcal/day energy deficit. Results: After 16 weeks, both diets had positive effects on various parameters, including weight loss, blood pressure, glucose control, lipid profile, and renal function. However, the low-carbohydrate diet appears to result in a greater reduction in BMI, blood pressure, waist circumference, glucose levels, lipid profiles, cardiovascular risk, renal markers, and overall metabolic parameters compared to the Mediterranean diet at the 16-week follow up. Conclusions: These findings suggest that a low-carbohydrate diet may be more effective than a Mediterranean diet in promoting weight loss and improving various metabolic and cardiovascular risk factors in overweight/obese patients with T2DM. However, it is important to note that further research is needed to understand the clinical implications and long-term sustainability of these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a 16-weeks intervention among postmenopausal women with overweight and type 2 diabetes, a mean weight loss of 7.6 kg was observed during MedDiet, whereas a LC group the reduction amounted to 9.1 kg [53].”
From Dietary and Behavioral Strategies for Weight Loss and Weight Loss Maintenance: A Narrative Review (2025) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · cited 1×
“…laboratory of the Policlinico Universitario Riuniti di Foggia to evaluate glucose, glycosylated hemoglobin (Hb1Ac), total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, creatinine, albuminuria, and e-Gfr, calculated using CKD-EPI equations for the glomerular filtration rate [35].”
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792 · cited 1×
“This under-scores the urgent need for effective therapeutic interventions to manage these conditions successfully [39].”
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“It has been reported that a 1% reduction in HbA1c levels leads to a 35% decrease in the risk of microvascular complications and reduces the risk of myocardial infarction and sudden death by 16% [2].”
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · cited 1×
“Projections indicate that by 2045, the number of people with diabetes around the world will increase significantly, with estimates suggesting that approximately 600 million individuals will be affected [1].”
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
A Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794 · cited 1×
“…potential alternative to the Mediterranean diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering…”
A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Nutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-2042 · Cited by 1,129 · cited 1×
“There is growing evidence leading to recommendations from numerous scientific medical societies of diabetology on the use of these dietary approaches to intervene against type 2 diabetes [16–18] and overall protection against cardiovascular diseases [19].”
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
The Mediterranean diet and health: a comprehensive overview
Guasch‐Ferré, M., & Willett, W. C. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13333 · Cited by 940 · cited 2×
“…and low-fat regimen (no more than 30% of total energy), emphasizing caloric restriction, increased fiber consumption, and focusing on vegetables, fruits, whole cereals, and legumes, in addition to lean proteins from fish and poultry and healthy fats such as extra virgin olive oil [14,15].”
Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., et al. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.011 · Cited by 912 · cited 2×
“LCDs thus promote a reduced demand for insulin secretion, facilitating improved glycemic control [63] and reducing glucose toxicity, oxidative stress, and inflammation which can affect beta-cell function [56].”
Ajala, O., English, P., & Pinkney, J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.042457 · Cited by 821 · cited 1×
“First, in line with a recent review and meta-analysis of Ajala et al. [59], our study showed that both MD and LCD diets resulted in a significant reduction in weight loss and improvement in blood pressure, glucose control, lipid profile, cardiovascular risk, and renal function after 16 weeks of…”
Schwingshackl, L., Hoffmann, G., Lampousi, A.-M., Knüppel, S., Iqbal, K., Schwedhelm, C., Bechthold, A., Schlesinger, S., & Boeing, H. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0246-y · Cited by 799 · cited 1×
“Achieving optimal blood glucose levels is a critical therapeutic goal while concurrently addressing concomitant comorbidities, such as dyslipidemia, hypertension, and albuminuria, which are intricately interrelated with the pathophysiology of hyperglycemia [3–5].”
The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
King, P., Peacock, I., & Donnelly, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00092.x · Cited by 695 · cited 1×
“To calculate the probability of a first major cardiovascular event in the next 10 years, we used the UKPDS risk engine, which is a specific risk calculator for type 2 diabetes based on 53,000 patients years of data from the UK Prospective Diabetes Study [36–38].”
Saturated fat, carbohydrate, and cardiovascular disease
Siri-Tarino, P. W., Sun, Q., Hu, F. B., & Krauss, R. M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26285 · Cited by 636 · cited 1×
“Additionally, low-carbohydrate diets promote the expression of genes involved in lipid metabolism, such as peroxisome proliferator-activated receptor alpha (PPAR α ), which enhances fatty acid oxidation and contributes to the improvement in blood lipid profiles [66,67].”
Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.068 · Cited by 629 · cited 1×
“Dietary interventions that institute a substantial negative calorie balance play a critical role in restoring normal pancreatic function and hepatic insulin sensitivity [7–9].”
Frankenfield, D., Roth-Yousey, L., & Compher, C. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.02.005 · Cited by 623 · cited 1×
“Firstly, the individual calorie requirement was calculated by estimating the basal metabolic rate (BMR) through Mifflin-St George equations, which consider the individual’s sex, age, weight, and height of overweight/obese subjects [34].”
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
Taylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485 · cited 1×
“Dietary interventions that institute a substantial negative calorie balance play a critical role in restoring normal pancreatic function and hepatic insulin sensitivity [7–9].”
Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes
Sheard, N. F., Clark, N. G., Brand-Miller, J. C., Franz, M. J., Pi-Sunyer, F. X., Mayer-Davis, E., Kulkarni, K., & Geil, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2266 · Cited by 475 · cited 1×
“There is growing evidence leading to recommendations from numerous scientific medical societies of diabetology on the use of these dietary approaches to intervene against type 2 diabetes [16–18] and overall protection against cardiovascular diseases [19].”
Consensus report: definition and interpretation of remission in type 2 diabetes
Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., Oh, W. K., Rothberg, A. E., le Roux, C. W., Rubino, F., Schauer, P., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0034 · Cited by 464 · cited 1×
“Additionally, achieving remission of type 2 diabetes is deemed possible through weight loss and intensive dietary changes [82].”
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463 · cited 1×
“Alterations in insulin signaling can disrupt these processes and contribute to glomerular dysfunction and increased permeability, leading to the leakage of albumin into the urine and alterations in creatinine levels [78,79].”
Grosso, G., Marventano, S., Yang, J., Micek, A., Pajak, A., Scalfi, L., Galvano, F., & Kales, S. N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1107021 · Cited by 456 · cited 1×
“There is growing evidence leading to recommendations from numerous scientific medical societies of diabetology on the use of these dietary approaches to intervene against type 2 diabetes [16–18] and overall protection against cardiovascular diseases [19].”
Self-citationKirkpatrick, C. F., Bolick, J. P., Kris-Etherton, P. M., Sikand, G., Aspry, K. E., Soffer, D. E., Willard, K.-E., & Maki, K. C. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2019.08.003 · Cited by 390
Lopes, R. D., Macedo, A. V. S., de Barros E Silva, P. G. M., Moll-Bernardes, R. J., dos Santos, T. M., Mazza, L., Feldman, A., D’Andréa Saba Arruda, G., de Albuquerque, D. C., Camiletti, A. S., et al. (2021) · JAMA · doi:10.1001/jama.2020.25864 · Cited by 364 · cited 1×
“Significantly lower insulin levels have also beneficial effects on blood pressure through the reduction in sodium reabsorption [75], norepinephrine [76], and angiotensin II release [77].”
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362 · cited 1×
“The American Diabetes Association (ADA) in 2023 Standards of Medical Care in Diabetes [80], and previously the British Diabetic Association in 2021 position statement, along with the Scientific Advisory Committee on Nutrition (SACN) report on lower carbohydrate diets for adults with type 2 diabetes…”
Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes
Wheeler, M. L., Dunbar, S. A., Jaacks, L. M., Karmally, W., Mayer-Davis, E. J., Wylie-Rosett, J., & Yancy, W. S. (2012) · Diabetes Care · doi:10.2337/dc11-2216 · Cited by 357
Snorgaard, O., Poulsen, G. M., Andersen, H. K., & Astrup, A. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000354 · Cited by 351
Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112581 · Cited by 341 · cited 1×
“…diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering drugs in patients with T2DM [23,53–57].”
Martín-Peláez, S., Fito, M., & Castaner, O. (2020) · Nutrients · doi:10.3390/nu12082236 · Cited by 330 · cited 1×
“The MD’s beneficial effect on diabetes is derived from its nutrient profile, which is particularly rich in fiber, complex carbohydrates, monounsatu-rated fats, antioxidants, and anti-inflammatory compounds [43,44].”
Browning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007674 · Cited by 328 · cited 1×
“…diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering drugs in patients with T2DM [23,53–57].”
Santos, F. L., Esteves, S. S., da Costa Pereira, A., Yancy Jr, W. S., & Nunes, J. P. L. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01021.x · Cited by 318 · cited 1×
“Therefore, the effects of LCD on blood lipids are mixed [69,70]; it usually appears that LDL cholesterol tends to increase, while triglycerides are drastically lowered and HDL cholesterol rises [71].”
A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men
Sharman, M. J., Kraemer, W. J., Love, D. M., Avery, N. G., Gómez, A. L., Scheett, T. P., & Volek, J. S. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.7.1879 · Cited by 312 · cited 1×
“Additionally, low-carbohydrate diets promote the expression of genes involved in lipid metabolism, such as peroxisome proliferator-activated receptor alpha (PPAR α ), which enhances fatty acid oxidation and contributes to the improvement in blood lipid profiles [66,67].”
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
Robins, S. J., Rubins, H. B., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W., Collins, D., & on behalf of the VA-HIT Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1513 · Cited by 308 · cited 1×
“Moreover, T2DM patients who suffer from ischemic heart disease display a greater degree of insulin resistance compared to those without coronary disease, even after controlling for other variables that may influence this association [10–13].”
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2019) · Endocrine Practice · doi:10.4158/cs-2018-0535 · Cited by 297 · cited 1×
“The modification of dietary and lifestyle factors represents a fundamental tenet in the treatment and management of type 2 diabetes mellitus and obesity [6].”
Low-density lipoprotein size and cardiovascular risk assessment
Rizzo, M., & Berneis, K. (2006) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hci154 · Cited by 260 · cited 1×
“A carbohydrate restricted diet increases the LDL peak particle size, thus becoming less atherogenic and decreases the numbers of total and small LDL particles [73], which may be a more relevant indicator of cardiovascular risk than total LDL cholesterol levels alone [74].”
Cavero-Redondo, I., Peleteiro, B., Álvarez-Bueno, C., Rodriguez-Artalejo, F., & Martínez-Vizcaíno, V. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015949 · Cited by 260
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s008 · Cited by 244 · cited 1×
“Achieving optimal blood glucose levels is a critical therapeutic goal while concurrently addressing concomitant comorbidities, such as dyslipidemia, hypertension, and albuminuria, which are intricately interrelated with the pathophysiology of hyperglycemia [3–5].”
BackgroundSaslow, L. R., Daubenmier, J. J., Moskowitz, J. T., Kim, S., Murphy, E. J., Phinney, S. D., Ploutz-Snyder, R., Goldman, V., Cox, R. M., Mason, A. E., et al. (2017) · Nutrition & Diabetes · doi:10.1038/s41387-017-0006-9 · Cited by 241
Saslow, L. R., Kim, S., Daubenmier, J. J., Moskowitz, J. T., Phinney, S. D., Goldman, V., Murphy, E. J., Cox, R. M., Moran, P., & Hecht, F. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091027 · Cited by 221 · cited 1×
“…diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering drugs in patients with T2DM [23,53–57].”
Meng, Y., Bai, H., Wang, S., Li, Z., Wang, Q., & Chen, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.006 · Cited by 221 · cited 1×
“LCDs thus promote a reduced demand for insulin secretion, facilitating improved glycemic control [63] and reducing glucose toxicity, oxidative stress, and inflammation which can affect beta-cell function [56].”
Insulin Resistance in Type 2 Diabetes - Role of the Adipokines
Arner, P. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766022 · Cited by 201 · cited 1×
“The reduction in adipose tissue decreases the release of proinflammatory adipokines, such as tumor necrosis factor-alpha (TNF-α ) and interleukin-6 (IL-6), which contribute to a low-grade systemic inflammation and insulin resistance [61].”
Mediterranean Diet and Cardiovascular Risk Factors: A Systematic Review
Grosso, G., Mistretta, A., Frigiola, A., Gruttadauria, S., Biondi, A., Basile, F., Vitaglione, P., D’Orazio, N., & Galvano, F. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.596955 · Cited by 191 · cited 1×
“Additionally, systematic reviews and meta-analyses reported that the MD was effective in reducing fasting blood glucose levels and glycated hemoglobin (HbA1c) in individuals with T2DM [41,42].”
Self-citationSaely, C. H., Aczel, S., Marte, T., Langer, P., Hoefle, G., & Drexel, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0799 · Cited by 191
Insulin resistance and hypertension: new insights
Soleimani, M. (2015) · Kidney International · doi:10.1038/ki.2014.392 · Cited by 176
Volek, J., Sharman, M., Gómez, A., Judelson, D., Rubin, M., Watson, G., Sokmen, B., Silvestre, R., French, D., & Kraemer, W. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-13 · Cited by 175 · cited 1×
“The decreased insulin levels promote the activation of hormone-sensitive li-Nutrients pase (HSL) that facilitates the breakdown of stored triglycerides in adipose tissue, releasing fatty acids into the bloodstream for energy utilization [64,65].”
Jing, T., Zhang, S., Bai, M., Chen, Z., Gao, S., Li, S., & Zhang, J. (2023) · Nutrients · doi:10.3390/nu15143156 · Cited by 139 · cited 1×
“Although there are numerous studies on the potential beneficial effects of low-carbohydrate diets on overweight diabetic patients, there is a paucity of scientific literature that directly compares the effects of an MD versus an LCD as seen in our study [58].”
The role of higher protein diets in weight control and obesity-related comorbidities
Astrup, A., Raben, A., & Geiker, N. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.216 · Cited by 137 · cited 1×
“These results may be explained firstly by the fact that low-carbohydrate diets perform better on weight loss in the short term (less than 6 months) especially on visceral adiposity [60].”
Adherence to a Mediterranean diet and glycaemic control in type 2 diabetes mellitus
Esposito, K., Maiorino, M. I., Di Palo, C., Giugliano, D., & for the Campanian Postprandial Hyperglycemia Study Group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02798.x · Cited by 102
Forsythe, C. E., Phinney, S. D., Feinman, R. D., Volk, B. M., Freidenreich, D., Quann, E., Ballard, K., Puglisi, M. J., Maresh, C. M., Kraemer, W. J., et al. (2010) · Lipids · doi:10.1007/s11745-010-3467-3 · Cited by 90 · cited 1×
“The decreased insulin levels promote the activation of hormone-sensitive li-Nutrients pase (HSL) that facilitates the breakdown of stored triglycerides in adipose tissue, releasing fatty acids into the bloodstream for energy utilization [64,65].”
Shimamoto, K., Hirata, A., Fukuoka, M., Higashiura, K., Miyazaki, Y., SHIIKI, M., Masuda, A., Nakagawa, M., & Iimura, O. (1994) · Hypertension · doi:10.1161/01.hyp.23.1_suppl.i29 · Cited by 77 · cited 1×
“Significantly lower insulin levels have also beneficial effects on blood pressure through the reduction in sodium reabsorption [75], norepinephrine [76], and angiotensin II release [77].”
A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review
Sukkar, S. G., & Muscaritoli, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.642628 · Cited by 73 · cited 1×
“In this context, a low-carbohydrate diet (LCD) has gained attention as a potential alternative to the Mediterranean diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content…”
Unwin, D., Delon, C., Unwin, J., Tobin, S., & Taylor, R. (2023) · BMJ Nutrition, Prevention & Health · doi:10.1136/bmjnph-2022-000544 · Cited by 72 · cited 1×
“…diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering drugs in patients with T2DM [23,53–57].”
Insulin: Trigger and Target of Renal Functions
Pina, A. F., Borges, D. O., Meneses, M. J., Branco, P. Q., Birne, R., Vilasi, A. D., & Macedo, M. P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00519 · Cited by 68 · cited 1×
“Alterations in insulin signaling can disrupt these processes and contribute to glomerular dysfunction and increased permeability, leading to the leakage of albumin into the urine and alterations in creatinine levels [78,79].”
Szczerba, E., Barbaresko, J., Schiemann, T., Stahl‐Pehe, A., Schwingshackl, L., & Schlesinger, S. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000664 · Cited by 65 · cited 1×
“Dietary fats, particularly saturated fatty acids (SFAs), have been implicated as the cause of the significant rise in obesity and its related diseases [24].”
Plant bioactive compounds from Mediterranean diet improve risk factors for metabolic syndrome
Farias‐Pereira, R., Zuk, J. B., & Khavaran, H. (2023) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2023.2232949 · Cited by 54 · cited 1×
“The MD’s beneficial effect on diabetes is derived from its nutrient profile, which is particularly rich in fiber, complex carbohydrates, monounsatu-rated fats, antioxidants, and anti-inflammatory compounds [43,44].”
Veldhorst, M. A. B., Westerterp, K. R., van Vught, A. J. A. H., & Westerterp-Plantenga, M. S. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510002060 · Cited by 50 · cited 1×
“…diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering drugs in patients with T2DM [23,53–57].”
Effect of low carbohydrate diets on insulin resistance and the metabolic syndrome
Foley, P. J. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000659 · Cited by 47
Sotos‐Prieto, M., Rio, D. D., Drescher, G., Estruch, R., Hanson, C., Harlan, T. S., Hu, F. B., Loi, M. A., McClung, J. P., Mojica, A., et al. (2021) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2021.1941804 · Cited by 45 · cited 1×
“…and low-fat regimen (no more than 30% of total energy), emphasizing caloric restriction, increased fiber consumption, and focusing on vegetables, fruits, whole cereals, and legumes, in addition to lean proteins from fish and poultry and healthy fats such as extra virgin olive oil [14,15].”
Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease
Inchiostro, S., Bertoli, G., Zanette, G., & Donadon, V. (1994) · Diabetologia · doi:10.1007/bf00403379 · Cited by 43 · cited 1×
“Moreover, T2DM patients who suffer from ischemic heart disease display a greater degree of insulin resistance compared to those without coronary disease, even after controlling for other variables that may influence this association [10–13].”
Falkenhain, K., Roach, L. A., McCreary, S., McArthur, E., Weiss, E. J., François, M. E., & Little, J. P. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab212 · Cited by 40 · cited 1×
“A carbohydrate restricted diet increases the LDL peak particle size, thus becoming less atherogenic and decreases the numbers of total and small LDL particles [73], which may be a more relevant indicator of cardiovascular risk than total LDL cholesterol levels alone [74].”
Firman, C., Mellor, D. D., Unwin, D., & Brown, A. C. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01492-4 · Cited by 33
Dietary Fats and Cardio-Metabolic Outcomes in a Cohort of Italian Adults
Currenti, W., Godos, J., Alanazi, A. M., Grosso, G., Cincione, R. I., Vignera, S. L., Buscemi, S., & Galvano, F. (2022) · Nutrients · doi:10.3390/nu14204294 · Cited by 31 · cited 1×
“…systematic reviews challenge the link between total SFA intake with cardiovascular disease and recent studies showed that short-chain saturated fatty acids (SCSFAs) especially from dairy foods [27–30] may exert potential beneficial effects both on metabolic and mental health outcomes [31–33].”
Self-citationLower carbohydrate diets for adults with type 2 diabetes
Singh, M. K., Hung, E. S., Cullum, A., Allen, R. E., Aggett, P. J., Dyson, P. A., Forouhi, N. G., Greenwood, D. C., Pryke, R., Taylor, R., et al. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002373 · Cited by 27 · cited 1×
“…statement, along with the Scientific Advisory Committee on Nutrition (SACN) report on lower carbohydrate diets for adults with type 2 diabetes [81], advocate for the effectiveness of a low-carbohydrate eating pattern in managing patients with type 2 diabetes or prediabetes who are not…”
Turton, J. L., Brinkworth, G. D., Field, R., Parker, H. M., & Rooney, K. B. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13837 · Cited by 26 · cited 2×
“…assessing the comparative effects of carbohydrate restricted diets versus low-fat control diets in overweight/obese patients with type 2 diabetes mellitus have shown divergent and inconclusive results regarding the impact on glycated hemoglobin, weight loss, and cardiovascular risk factors [20–26].”
InfluentialCardiometabolic impacts of saturated fatty acids: are they all comparable?
Bloise, A. M. N. D. L. G., Simões-Alves, A. C., Alves, D., Morio, B., & Costa‐Silva, J. H. (2021) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2021.1940885 · Cited by 26 · cited 1×
“…systematic reviews challenge the link between total SFA intake with cardiovascular disease and recent studies showed that short-chain saturated fatty acids (SCSFAs) especially from dairy foods [27–30] may exert potential beneficial effects both on metabolic and mental health outcomes [31–33].”
Dietary Fats and Cognitive Status in Italian Middle-Old Adults
Currenti, W., Godos, J., Alanazi, A. M., Lanza, G., Ferri, R., Caraci, F., Grosso, G., Galvano, F., & Castellano, S. (2023) · Nutrients · doi:10.3390/nu15061429 · Cited by 26
Self-citationDietary Fats and Depressive Symptoms in Italian Adults
Currenti, W., Godos, J., Alanazi, A. M., Lanza, G., Ferri, R., Caraci, F., Galvano, F., Castellano, S., & Grosso, G. (2023) · Nutrients · doi:10.3390/nu15030675 · Cited by 25 · cited 1×
“…systematic reviews challenge the link between total SFA intake with cardiovascular disease and recent studies showed that short-chain saturated fatty acids (SCSFAs) especially from dairy foods [27–30] may exert potential beneficial effects both on metabolic and mental health outcomes [31–33].”
Self-citationSantamarina, A. B., Mennitti, L. V., de Souza, E. A., Mesquita, L. M. D. S., Noronha, I. H., Vasconcelos, J. R., Prado, C. M., & Pisani, L. P. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.09.024 · Cited by 23 · cited 1×
“For the low-carbohydrate diet, as per definition [29], a quantity of carbohydrates less than 130 g was administered, while for the Mediterranean diet, a quantity of carbohydrates, as per definition, exceeding 45% (about 55”
Low-Carbohydrate and Low-Fat Diet with Metabolic-Dysfunction-Associated Fatty Liver Disease
Hu, C., Huang, R., Li, R., Ning, N., He, Y. J., Zhang, J., Wang, Y., Ma, Y., & Jin, L. (2023) · Nutrients · doi:10.3390/nu15224763 · Cited by 23
Rad, Z. A., Mousavi, S. N., & Chiti, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-45054-x · Cited by 20 · cited 1×
“…systematic reviews challenge the link between total SFA intake with cardiovascular disease and recent studies showed that short-chain saturated fatty acids (SCSFAs) especially from dairy foods [27–30] may exert potential beneficial effects both on metabolic and mental health outcomes [31–33].”
Qin, P., Suo, X., Chen, S., Huang, C., Wen, W., Lin, X., Hu, D., & Bo, Y. (2023) · Food & Function · doi:10.1039/d3fo01374j · Cited by 18 · cited 1×
“Therefore, the effects of LCD on blood lipids are mixed [69,70]; it usually appears that LDL cholesterol tends to increase, while triglycerides are drastically lowered and HDL cholesterol rises [71].”
Opposite effects of low-carbohydrate high-fat diet on metabolism in humans and mice
Cai, L., Xia, X., Gu, Y., Hu, L., Li, C., Ma, X., & Yin, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01956-3 · Cited by 18 · cited 1×
“…assessing the comparative effects of carbohydrate restricted diets versus low-fat control diets in overweight/obese patients with type 2 diabetes mellitus have shown divergent and inconclusive results regarding the impact on glycated hemoglobin, weight loss, and cardiovascular risk factors [20–26].”
Influence of Habitual Dairy Food Intake on LDL Cholesterol in a Population-Based Cohort
Buscemi, S., Corleo, D., Buscemi, C., Randazzo, C., Borzì, A. M., Barile, A. M., Rosafio, G., Ciaccio, M., Caldarella, R., Meli, F., et al. (2021) · Nutrients · doi:10.3390/nu13020593 · Cited by 17
Self-citationGram-Kampmann, E.-M., Olesen, T. B., Hansen, C. D., Hugger, M. B., Jensen, J. M., Handberg, A., Beck‐Nielsen, H., Krag, A. A., Olsen, M. H., & Højlund, K. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01956-8 · Cited by 17 · cited 1×
“…71 patients with type 2 diabetes showed that LCD does not adversely affect endothelial function and markers of inflammations as interleukin-6 (IL-6) or high-sensitivity C-reactive protein (hsCRP), demonstrating that this dietary approach does not increase the risk of cardiovascular disease [72].”
Sacks, F. M., & Andraski, A. B. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000809 · Cited by 14 · cited 1×
“Moreover, low-carbohydrate diets may enhance the activity of enzymes involved in HDL metabolism, such as lecithin-cholesterol acyltransferase (LCAT), leading to increased HDL cholesterol synthesis and clearance [68].”
Surma, S., Sahebkar, A., Banach, M., & (ILEP), E. B. T. I. L. E. P. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad635 · Cited by 8 · cited 1×
“Therefore, the effects of LCD on blood lipids are mixed [69,70]; it usually appears that LDL cholesterol tends to increase, while triglycerides are drastically lowered and HDL cholesterol rises [71].”
Barouti, A. A., Björklund, A., Catrina, S., Brismar, K., & Ekberg, N. R. (2023) · Nutrients · doi:10.3390/nu15143092 · Cited by 7 · cited 2×
“This is supported by a joint consensus statement in 2021 from the American Diabetes Association (ADA), the Endocrine Society, the European Association for the Study of Diabetes, and Diabetes UK [62].”
Magkos, F., Ataran, A., Javaheri, A., & Mittendorfer, B. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000946 · Cited by 3 · cited 1×
“…alternative to the Mediterranean diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering…”
Yen, F., Lee, P.-C., & Hwu, C. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14029 · Cited by 3 · cited 1×
“…diet [45], particularly in the short term, due to its ability to facilitate greater initial weight loss [46–48], promote satiety and reduce hunger [49], decrease liver fat content [50–52], improve glycemic control and reduce the need for glucose lowering drugs in patients with T2DM [23,53–57].”
Kanaya, A. M., Grady, D., & Barrett-Connor, E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1737 · Cited by 1 · cited 1×
“To calculate the probability of a first major cardiovascular event in the next 10 years, we used the UKPDS risk engine, which is a specific risk calculator for type 2 diabetes based on 53,000 patients years of data from the UK Prospective Diabetes Study [36–38].”
Cited by
Li, D., Jia, L., Wu, X.-L., & Cheng, M. Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s508365 · Cited by 69
“38 Additionally, the sample size, while sufficient for detecting significant correlations, may not be large enough to generalize these findings to more diverse populations.”
Nurkolis, F., Harbuwono, D. S., Taslim, N. A., Soegondo, S., Suastika, K., Sparringa, R. A., Mustika, A., Syam, A. F., Santini, A., Holly, J. M. P., et al. (2025) · Discover Food · doi:10.1007/s44187-025-00422-6 · Cited by 49
“In longitudinal studies involving patients with type 2 diabetes, participants who adopted the Mediterranean diet over one year demonstrated a significant reduction in HbA1c levels and improved insulin sensitivity [38, 62].”
Two-Year Mediterranean Diet Intervention Improves Hepatic Health in MASLD Patients
Monserrat-Mesquida, M., Bouzas, C., García, S., Mateos, D., Casares, M., Ugarriza, L., Gómez, C., Sureda, A., & Tur, J. A. (2025) · Foods · doi:10.3390/foods14101736 · Cited by 23
“Additionally, it supports cardiovascular health, metabolic function, and sustainable lifestyle changes, potentially reducing the risk of obesity-related conditions such as type 2 diabetes and cardiovascular disease [33,34].”
Dietary and Behavioral Strategies for Weight Loss and Weight Loss Maintenance: A Narrative Review
Żurawski, T., & Bartosiewicz, A. (2025) · Nutrients · doi:10.3390/nu18010012 · Cited by 18
“In a 16-weeks intervention among postmenopausal women with overweight and type 2 diabetes, a mean weight loss of 7.6 kg was observed during MedDiet, whereas a LC group the reduction amounted to 9.1 kg [53].”
InfluentialMartínez‐Montoro, J. I., Bandera-Merchán, B., Gutiérrez‐Bedmar, M., Gómez‐Pérez, A. M., Macías‐González, M., Moreno‐Indias, I., & Tinahones, F. J. (2025) · BMC Medicine · doi:10.1186/s12916-025-04182-z · Cited by 19
“On the other hand, in a 16-week trial performed in patients with overweight/obesity and type 2 diabetes, a low-carbohydrate diet resulted in greater weight loss than a MedDiet (both diets were calorie-restricted) [18].”
Metadata
- Authors
- Currenti, W., Losavio, F., Quiete, S., Alanazi, A. M., Messina, G., Polito, R., Ciolli, F., Zappalà, R. S., Galvano, F., & Cincione, R. I.
- Affiliations
- University of Catania (IT)
- University of Foggia (IT)
- King Saud University (SA)
- Corresponding author
- Currenti, Walter
- Galvano, Fabio
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-12-27
- Volume
- 16
- Issue
- 1
- Pages
- 95
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10781045
- OpenAlex
- W4390267934
- Cited by
- 23
- References
- 84
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 4
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Distinguished Scientist Fellowship Program (DSFP)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- low-carbohydrate diet, Mediterranean diet, type 2 diabetes, obesity, overweight, weight loss, glycemic control, lipid profile, blood pressure, cardiovascular risk factors, renal function, negative energy balance, dietary intervention
- MeSH terms
- Carbohydrates, Diabetes Mellitus, Type 2, Humans, Lipids, Obesity, Quality of Life, Weight Loss, Diet, Mediterranean, Overweight, Diet, Carbohydrate-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
